SR protein-specific kinase-1 (SRPK-1) has been identified as a validated target for hepatitis B virus (HBV). A series of novel tricyclic quinoxaline derivatives was designed and synthesised as potential kinase inhibitory antiviral agents and was found to be active and selective for SRPK-1 kinase. Most of these novel compounds have drug-like properties according to experimentally determined LogP and LogS values.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmcl.2005.04.064 | DOI Listing |
Publication Analysis
Top Keywords
selective srpk-1
8
novel tricyclic
8
tricyclic quinoxaline
8
quinoxaline derivatives
8
synthesis selective
4
srpk-1 inhibitors
4
inhibitors novel
4
derivatives protein-specific
4
protein-specific kinase-1
4
kinase-1 srpk-1
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!